Anagenics Ltd
AN1
Company Profile
Business description
Anagenics Ltd is a health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. It develops and sells differentiated and clinically validated solutions for a range of conditions associated with aging. It includes validated consumer products to help people live longer, in good health, and with confidence. Its brands include Evolis and Uspa.
Contact
55 Clarence Street
Suite 204, Level 2
SydneyNSW2000
AUST: +61 292216830
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
ASX healthcare giant remains well positioned despite share slump
We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks
Australian bank remains overvalued despite strong result
When strong fundamentals meet persistent valuation headwinds.
stocks
Chart of the Week: Soft earnings growth outlook for Australian banks
The latest take from our equity research analysts.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,303.20 | 118.70 | 1.29% |
| CAC 40 | 8,313.24 | 14.64 | -0.18% |
| DAX 40 | 24,856.15 | 131.70 | -0.53% |
| Dow JONES (US) | 50,121.40 | 66.74 | -0.13% |
| FTSE 100 | 10,479.60 | 125.76 | 1.21% |
| HKSE | 27,045.77 | 137.38 | -0.51% |
| NASDAQ | 23,066.47 | 36.01 | -0.16% |
| Nikkei 225 | 57,605.53 | 45.01 | -0.08% |
| NZX 50 Index | 13,493.01 | 46.64 | 0.35% |
| S&P 500 | 6,941.47 | 0.34 | -0.00% |
| S&P/ASX 200 | 9,062.10 | 146.10 | 1.64% |
| SSE Composite Index | 4,139.63 | 7.65 | 0.19% |